The most popular, commercialized weight loss medications were initially used as medication to treat type 2 diabetes. Although they are still used to treat type 2 diabetes, they are also effective medications that help individuals lose weight . The three most common of these are Ozempic, Wegovy, and Mounjaro. They are all GLP1 receptor agonists, which means they stimulate insulin production and inhibit glucagon production.
These three medications are very similar.
What is compounded semaglutide?
Semaglutide is an injectable weight loss medication, similar to brand equivalents like Ozempic, Wegovy, and Mounjaro. Compounded semaglutide allow us to tailor the medication to patients’ specific needs.
How Semaglutide Works
After you eat a meal, the hormone GLP-1 begins a chain reaction by increasing insulin and lowering glucagon (the hormone responsible for eating). Because of this reaction, there is a delay in the body’s gastric emptying, which sends signals to the brain that the stomach is full. Secondly, GLP-1 receptors bind to the brain appetite centers, reducing cravings.
Studies have shown, patients are able to achieve a weight loss of 15% of their body weight on this drug.
We use this same drug in our VitaFusion Doctors Weight Loss Program. Our formulation contains vitamin B12 which may help alleviate some common side effects of these medications such as nausea and stomach upset.
Can Lipo-Mix & Semaglutide be combined?
Lipo-Mix and semaglutide can be combined, as some of the ingredients in lipotropic injections may be beneficial in aiding the semaglutide. Some ingredients in Lipo-Mix can aid in semaglutide side effects and boost weight loss further. For example, B6, a vitamin often included in Lipo-Mix injections, can help aid with common side effects such as nausea. Along with this, L-carnitine, which is found in Lipo-Mix, is an amino acid that aids in metabolism and fat mobilization.
As a result, the combination of lipotropic injections and semaglutide can lead to more effective weight loss and less intensive side effects. For some patients, this combination may be a more effective and helpful alternative to commercial weight loss medications.
Limitations of use:
Not to be used in pregnancy, history of pancreatitis, Type 1 diabetes, personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type II
Warnings & Precautions:
Pancreatitis: Has been reported in clinical trials.
- Diabetic Retinopathy Complications: Has been reported in a clinical trial. Patients with a history of diabetic retinopathy should be monitored
- Hypoglycemia: Concomitant use with an insulin secretagogue or insulin may increase the risk of hypoglycemia, including severe hypoglycemia. Reducing dose of insulin secretagogue or insulin may be necessary.
- Acute Kidney Injury: Monitor renal function in patients with renal impairment reporting severe adverse gastrointestinal reactions
- Hypersensitivity Reactions: Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported.
- Acute Gallbladder Disease: If cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated